Arkolith/Insider Trading/AMRX/Form 4

Daly Jason B.

EVP, Chief Legal OfficerAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
15
10 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Tax withholding(F)16K$13.30$207K252K
Mar 4, 2026Option exercise(M)36K——267K
Mar 3, 2026Option exercise(M)23K——33K
Mar 3, 2026Option exercise(M)24K——69K
Mar 3, 2026Tax withholding(F)17K$13.31$221K45K
Mar 3, 2026Option exercise(M)38K——61K
Mar 3, 2026Tax withholding(F)10K$13.31$135K23K
Mar 3, 2026Tax withholding(F)11K$13.31$140K58K
Mar 3, 2026Tax withholding(F)133K$13.31$1.8M231K
Mar 3, 2026Option exercise(M)306K——364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)36K—$072K
Mar 3, 2026Option exercise(M)306K—$00
Mar 3, 2026Option exercise(M)24K—$073K
Mar 3, 2026Option exercise(M)38K—$038K
Mar 3, 2026Option exercise(M)23K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015241) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML